Smoldering Adult T-cell Leukemia Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-03-01
Clinical Trial Update: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma [Phase 2]
Phase 2 trial of nivolumab in HTLV-1–associated adult T-cell leukemia/lymphoma has completed and results were posted in 2019.